Palantir a high-risk investment with ’a one-of-a-kind growth and margin model’
LONDON - CVS Group plc, a leading provider of veterinary services, has acknowledged the Competition and Markets Authority’s (CMA) decision to extend the statutory deadline for its investigation into the UK veterinary services market. The extension will allow the CMA to fully consider industry feedback on proposed remedies aimed at increasing transparency in the supply of veterinary services for household pets.
The company has been actively participating in discussions with the CMA, advocating for transparency measures that address the regulator’s concerns without imposing undue burdens on veterinary practices or compromising animal welfare. CVS has expressed support for the CMA’s focus on improving communication and transparency but has cautioned against remedies that could restrict veterinarians’ clinical independence.
CVS Group CEO Richard Fairman conveyed optimism that the extended period for review would result in a balanced and proportionate remedy package. However, he also recognized the impact of the ongoing uncertainty on CVS employees and other stakeholders, promising continued support throughout the extended review process.
The CMA’s market review, which began on September 7, 2023, has involved CVS Group since its inception. The company, which operates approximately 460 veterinary practices and employs about 9,000 personnel, including around 2,400 veterinary surgeons, has been a collaborative partner in the review.
The extension granted by the CMA aims to ensure that any interventions are carefully considered and that their implications for the veterinary industry and pet owners are thoroughly understood. CVS Group’s engagement with the CMA reflects its commitment to maintaining high standards of animal care while also addressing the regulatory concerns.
The information presented in this article is based on a press release statement from CVS Group plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.